Nombre del producto:3-amino-1-propan-2-ylpyrazole-4-carbonitrile

IUPAC Name:3-amino-1-(propan-2-yl)-1H-pyrazole-4-carbonitrile

CAS:89897-29-0
Fórmula molecular:C7H10N4
Pureza:95%+
Número de catálogo:CM336694
Peso molecular:150.19

Unidad de embalaje Stock disponible Precio($) Cantidad
CM336694-1g in stock ƃƛǑ
CM336694-5g in stock Ȑƃŵ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :89897-29-0
Fórmula molecular:C7H10N4
Punto de fusión:-
Código de sonrisas:N#CC1=CN(C(C)C)N=C1N
Densidad:
Número de catálogo:CM336694
Peso molecular:150.19
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

Encorafenib plus Binimetinib
U.S. FDA approved Pfizer's BRAFTOVI® (Encorafenib) + MEKTOVI® (Binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA's approval is based on data from the ongoing Phase 2 PHAROS clinical trial. Encorafenib is an oral small molecule BRAF kinase inhibitor, and Binimetinib is an oral small molecule MEK inhibitor targeting key proteins in the MAPK signaling pathway (RAS-RAF-MEK-ERK).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.